Posts in tag

PBS


The Society of Hospital Pharmacists of Australia has declared its support for faster and improved access to vital medicines and medical devices as announced in the 2016 Federal Budget. “The …

The cost of everyday medicines is set to drop by up to half from October 2016, Sussan Ley said in a statement regarding the 2016 Budget today. “Access to vital …

A roundup of the latest changes to the PBS There have been a number of changes to the PBS from 1 May. Among the new items listed are four Norspan …

Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. …

Pharmacy is not getting the credit it deserves in creating savings through PBS reforms, Guild executive director David Quilty writes in this week’s edition of Forefront – and so it …

Latest PBS cuts just the beginning, Minister believes A “skyrocketing” number of medicines experiencing a reduction in their price in the April round of PBS cuts is only the beginning, …

Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April, say Medicines Australia, the Generic and Biosimilar Medicines Association, …

Most pharmacies offering co-pay discount, Minister claims as first 6CPA trials are revealed More than three quarters of Australian pharmacies have offered the PBS co-pay discount, federal Minister for Health …

Be honest about the true cost of the $1 discount, Guild urges pharmacists Australian pharmacists must be honest about the impact of the $1 PBS co-pay discount on their chances …

The sustainability of the PBS has been highlighted by the release of Productivity Commission data which puts the cost of the PBS per person at a 10 year low, says …

The Government’s desire to control community pharmacy is starting to look dangerously Soviet, writes Peter Feros The Soviet era is long gone, but its spirit felt alive and well as …

The PBS delisting of Panadol Osteo needs to be reconsidered in the light of cost and clinical safety implications, says Painaustralia. The organisation has highlighted the risk of adverse clinical …